An organoid is a group of cells that are differentiated from stem or progenitor cells in an in vitro three-dimensional (3D) culture model. It has a structure and some functions similar to real organs. By imitating the development process of organs in the body, organoids can somewhat replicate the physiological activities and structural features of natural tissues or organs.
Organoids consist mostly of cell types, matrix and growth factors, and cytokines, which all work to build them up and function.
1. Cell source: For the organoid fabrication we need suitable cell sources such as pluripotent stem cells (embryonic stem cells and induced pluripotent stem cells) and organ-specific adult stem cells (intestinal stem cells). They can self-renew and differentiate into different cell types, and form the basis of organoids.
2. Basic medium: It is the heart of organoid culture and usually prepared using modified DMEM/F12 or another suitable medium. Different organoids might need different basal media. Retinal and gastric organoids might be cultured with a modified form of DMEM/F12; lung organoids might be cultured on RMPI-1640 medium.
3. Growth factors and cytokines: Growth factors and cytokines are what induces the growth and differentiation of organoids. There are epidermal growth factor (EGF), fibroblast growth factor (FGF), Wnt3A, R-Spondin-1, Noggin, etc. They proliferate, differentiate and remodel cells into tissues via signalling networks.
4. Mats and matrigel: Support organoids three-dimensionally. Other popular matrigels are Matrigel, which mimics the activity of mammalian cells' basement membrane and permits them to stick and differentiate.
6. Other Ingredients: Small molecules: like FGF4, MAPK inhibitors, etc. Such nanomoles can also control individual signalling pathways and drive the organoids' further growth and maturation.
The reasonable integration and tuning of these elements allows robust functions and complex organoids to be made – and will be valuable for disease studies, drug discovery and regenerative medicine.
Figure 1 Sources of cells employed for the development of 3D organoid models. 1,4
Figure 2. Construction process of bone organoids.2,4
Making organoids is a complex and highly technical task that requires a combination of multiple technologies and methods to achieve. Successful organoid development requires not only suitable cell sources and culture media, but also precise environmental simulation and operation techniques.
Organoids are categorized based on germ layer origin, cell source, developmental complexity, functional application, and culture methodology. Below is a detailed breakdown:
Reflects embryonic lineage and tissue specificity.
Germ Layer | Organoid Types | Examples | Key Features |
Endoderm | Gastrointestinal organoids, hepatic organoids | Intestinal organoids, Liver organoids, Pancreatic organoids | Epithelial polarization; crypt-villus structures (intestine) |
Mesoderm | Renal organoids, cardiovascular organoids | Kidney organoids, Heart organoids, Blood Vessels organoids | Mesenchymal components (e.g., nephrons, cardiomyocytes) |
Ectoderm | Neural organoids, epidermal organoids | Cerebral organoids, Retinal organoids, Skin organoids | Stratified layers (e.g., cortical neurons in brain organoids) |
Distinguishes between adult and pluripotent stem cell origins.
Cell Source | Organoid Types | Examples | Advantages/Limitations |
Adult Stem Cells (ASCs) | Tissue-specific self-renewal organoids | Intestinal organoids, Liver organoids, Prostate organoids | Limited lineage potential; high genetic stability |
Pluripotent Stem Cells (PSCs) | Directed differentiation models organoids | Cerebral organoids, Kidney organoids, Retinal organoids | Broad differentiation; models development/disease; ethical concerns (ESCs) |
Directly Reprogrammed Cells | Induced lineage conversion organoids | Hepatocyte-like organoids, Neuron-like organoids | Bypasses pluripotency; faster generation; partial functionality |
Stages reflect structural and functional maturation.
Stage | Characteristics | Examples |
Pre-patterning | Initial cell aggregation; no tissue architecture | Early PSC-derived spheroids |
Proto-organoids | Basic polarity; partial differentiation | Immature intestinal organoids |
Mature Organoids | Functional units (e.g., crypts, nephrons) | Kidney with glomeruli-tubule systems |
Vascularized | Endothelial integration; perfusion potential | Engineered liver/heart organoids |
Tailored for research, therapy, or industrial use.
Application | Organoid Types | Examples | Use Cases |
Disease Modeling | Patient-derived or gene-edited organoids | Cystic fibrosis (intestinal) organoids, Alzheimer's (cerebral) organoids | Pathogenesis studies; personalized therapy |
Drug Development | High-throughput screening platforms | Liver (toxicity) organoids, Tumor (oncology) organoids | Efficacy/toxicity testing; reduces animal use |
Regenerative Grafts | Bioengineered transplantable tissues | Skin organoids, Corneal organoids, Cardiac patches organoids | Tissue repair; reduces donor dependency |
Host-Pathogen Studies | Infectious disease models | COVID-19 (lung), Zika (brain) | Viral entry/replication mechanisms |
Techniques influencing physiological relevance and scalability.
System | Characteristics | Examples |
Hydrogel-Embedded | ECM-supported (e.g., Matrigel, collagen) | Intestinal organoids, Cerebral organoids |
Suspension Culture | Agitation-based; scalable production | Tumor spheroids, Liver organoids |
Air-Liquid Interface (ALI) | Enhanced oxygenation; mimics mucosal surfaces | Lung organoids, Colon organoids |
Microfluidic-Integrated | Perfusable; multi-organ interactions | Heart-liver chip organoids, Blood-brain barrier models |
Figure 3. Schematic of the different organoids that can be derived from PSCs.3,4
Organoids are important biological models widely used in medical research and biotechnology
Application Area | Description |
Disease Modeling | Simulate specific diseases (e.g., cancer, genetic disorders) to help understand their mechanisms. |
Drug Development | Test the safety and efficacy of drugs, providing more accurate data on human responses. |
Personalized Medicine | Develop personalized treatment plans based on organoids derived from patient cells. |
Regenerative Medicine | Repair or replace damaged tissues or organs, promoting advancements in regenerative medicine. |
Basic Research | Study cell interactions and responses to environmental changes, advancing fundamental biology. |
Developmental Biology Research | Investigate key mechanisms in organ development and reveal causes of developmental abnormalities. |
As an emerging in vitro model, organoids provide important tools for medical research and clinical applications. Their diverse applications make them valuable in the future of biomedical research.
There are several benefits of organoids that have caught more and more attention in biomedical research and clinical practice.
Organoids can self-assemble in 3D environment, in vitro, to create tiny organ-like structures and even keep a few key functions of organs. 3D organoids can be used to better mimic cell differentiation, tissue architecture and organ function in live organisms enabling researchers to really gain a grip on the biology of organ development and function (especially in complex organs (brain, liver, kidney, etc.) ).
Organoid technology overcomes the ethical and biological inconsistencies of standard animal experiments, compensating for the impossibility of 2-D cell culture. organoids are easier to work with, the modelling cycle is shorter, they are cheap, and can more precisely model human biological activity than animal models.
The organoids could be made of patient cells that are also atypical, supporting the personalized medicine. In tumor research, for instance, patient derived tumor organoids (PDO) can be used to experiment with the effect of various drugs on tumour cells to decide which strategy will be best.
Organoid can be used to make the process of drug discovery and screening much quicker, reveal how the drug acts in particular organs, and give insight into how to tailor a drug's performance and the way to treat it. Moreover, organoid models have high throughput and efficiency in drug screening.
Organoid technology also has promise for regenerative medicine. It can be differentiated into specific cells that constitute target tissues through long-term culture and stability expansion for repair of damaged tissues or transplantation therapy. This approach is both safe and immune rejection-resistant.
Genes and disease pathways can be mapped onto organoid systems with today's genetic engineering techniques. By editing genes, for instance, scientists can check how organoids respond to particular gene mutations.
Organoids are an in vitro culture technology without the risk of animal experiments, and organoids, as a non-invasive technique, are shorter in culture time and cheaper than animal and cell line models, as well as more economic benefit.
Creative Biolabs offers a range of innovative 3d organoids related solution to enhance scientific research. Below is a concise list detailing some of our standout services and products:
3d organoids related services
3d organoids related Products
If you're interested in advancing your research with our state-of-the-art solutions, welcome to contact our support team.
References